

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 5.98223636 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.89372115 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.78158035 |
| 4 | regulation of regulatory T cell differentiation (GO:0045589) | 5.41218293 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.35431227 |
| 6 | response to interleukin-15 (GO:0070672) | 5.31022377 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.28569144 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.28569144 |
| 9 | DNA deamination (GO:0045006) | 5.18048572 |
| 10 | negative T cell selection (GO:0043383) | 5.17251337 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.16907670 |
| 12 | cytidine metabolic process (GO:0046087) | 5.15592408 |
| 13 | cytidine catabolic process (GO:0006216) | 5.15592408 |
| 14 | cytidine deamination (GO:0009972) | 5.15592408 |
| 15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.95214833 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.93584249 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.69126010 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.60953201 |
| 19 | T cell migration (GO:0072678) | 4.60741780 |
| 20 | positive T cell selection (GO:0043368) | 4.56326457 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.54184153 |
| 22 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.49208398 |
| 23 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.41505406 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.40144289 |
| 25 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.29992202 |
| 26 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.28459863 |
| 27 | negative regulation of T cell apoptotic process (GO:0070233) | 4.28200776 |
| 28 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.25581424 |
| 29 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.17958590 |
| 30 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.17958590 |
| 31 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.15785547 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.07520822 |
| 33 | thymic T cell selection (GO:0045061) | 3.99156274 |
| 34 | positive regulation of cell killing (GO:0031343) | 3.98396365 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 3.96455926 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.88622224 |
| 37 | tolerance induction (GO:0002507) | 3.87864709 |
| 38 | regulation of cell killing (GO:0031341) | 3.86404387 |
| 39 | regulation of activation of Janus kinase activity (GO:0010533) | 3.83590282 |
| 40 | T cell selection (GO:0045058) | 3.77411247 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.77225799 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.74172513 |
| 43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.71120004 |
| 44 | interferon-gamma production (GO:0032609) | 3.69224557 |
| 45 | mast cell activation (GO:0045576) | 3.68914649 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.65730930 |
| 47 | T cell receptor signaling pathway (GO:0050852) | 3.60882391 |
| 48 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.58400494 |
| 49 | negative regulation by host of viral transcription (GO:0043922) | 3.56565066 |
| 50 | positive regulation of defense response to virus by host (GO:0002230) | 3.55949342 |
| 51 | positive regulation of interleukin-17 production (GO:0032740) | 3.53650255 |
| 52 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.50842110 |
| 53 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48370491 |
| 54 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.47870333 |
| 55 | T-helper cell differentiation (GO:0042093) | 3.47870333 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47592752 |
| 57 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.46600517 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45534950 |
| 59 | natural killer cell activation (GO:0030101) | 3.38415881 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.37831361 |
| 61 | T cell differentiation (GO:0030217) | 3.36982969 |
| 62 | positive regulation of T cell mediated immunity (GO:0002711) | 3.35781750 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.35315884 |
| 64 | alpha-beta T cell differentiation (GO:0046632) | 3.34872929 |
| 65 | positive regulation of interleukin-4 production (GO:0032753) | 3.34210880 |
| 66 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.25481423 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.22811661 |
| 68 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.22770465 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19912629 |
| 70 | regulation of chronic inflammatory response (GO:0002676) | 3.19853809 |
| 71 | alpha-beta T cell activation (GO:0046631) | 3.16848703 |
| 72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.16012170 |
| 73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.16012170 |
| 74 | T cell differentiation involved in immune response (GO:0002292) | 3.16012170 |
| 75 | actin nucleation (GO:0045010) | 3.14434453 |
| 76 | cellular defense response (GO:0006968) | 3.13523615 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12331609 |
| 78 | dendritic cell chemotaxis (GO:0002407) | 3.09628885 |
| 79 | T cell costimulation (GO:0031295) | 3.09285150 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08404118 |
| 81 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.06490207 |
| 82 | lymphocyte costimulation (GO:0031294) | 3.04938712 |
| 83 | regulation of T cell mediated immunity (GO:0002709) | 3.04068299 |
| 84 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.03261510 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02418627 |
| 86 | cytolysis (GO:0019835) | 3.01730002 |
| 87 | T cell activation (GO:0042110) | 3.00061037 |
| 88 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.99653343 |
| 89 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.99407694 |
| 90 | positive regulation of T cell chemotaxis (GO:0010820) | 2.98716125 |
| 91 | regulation of T cell chemotaxis (GO:0010819) | 2.98716125 |
| 92 | lymphocyte migration (GO:0072676) | 2.97915178 |
| 93 | regulation of T cell apoptotic process (GO:0070232) | 2.97879466 |
| 94 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97851579 |
| 95 | regulation of defense response to virus by host (GO:0050691) | 2.96068683 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 2.92294106 |
| 97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90708596 |
| 98 | mast cell degranulation (GO:0043303) | 2.89611740 |
| 99 | mast cell activation involved in immune response (GO:0002279) | 2.89611740 |
| 100 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.89212716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.27621194 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.14714858 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.61926538 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59055654 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.68008464 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.57205686 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.41753892 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32673548 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22006722 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.78241844 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.78015257 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.76376626 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74407191 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62850435 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.50490373 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47488909 |
| 17 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.41586089 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35097195 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.28146765 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27616856 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 2.17972449 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15064775 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.07360770 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04408142 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03621481 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02564453 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.99027401 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.88051299 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77252039 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.68927156 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.68501558 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64177476 |
| 33 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.58471768 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56032308 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55240601 |
| 36 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54704690 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51774307 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50053262 |
| 39 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.48341847 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.45099340 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42781089 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36757536 |
| 43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.36618112 |
| 44 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.36240066 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35756962 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34422873 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33110301 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32229177 |
| 49 | GATA3_26560356_Chip-Seq_TH1_Human | 1.31740589 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.26677690 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23967945 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21542679 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17037949 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15947823 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15782398 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14068438 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13621421 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12819520 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11452270 |
| 60 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10430206 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07627492 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05403425 |
| 63 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02388844 |
| 64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01381599 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00633656 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99915368 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99508421 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98989561 |
| 69 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94554417 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93843425 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93417274 |
| 72 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92735992 |
| 73 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92494603 |
| 74 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.91677326 |
| 75 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91023271 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90985294 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90975625 |
| 78 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90347398 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89985005 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89204022 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88009787 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87871662 |
| 83 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87522570 |
| 84 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87522570 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87405626 |
| 86 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87065948 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86437154 |
| 88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85495374 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84968532 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84470028 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.83572246 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83368374 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83321409 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82829588 |
| 95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82513237 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81341820 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81014668 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80997744 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80892103 |
| 100 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.80800219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.69185408 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.77625629 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.73920243 |
| 4 | MP0009785_altered_susceptibility_to | 3.46501658 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.15265568 |
| 6 | MP0001800_abnormal_humoral_immune | 2.99390690 |
| 7 | MP0003724_increased_susceptibility_to | 2.80983054 |
| 8 | MP0002723_abnormal_immune_serum | 2.75182509 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.71257323 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.71094623 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.67720810 |
| 12 | MP0001819_abnormal_immune_cell | 2.66641185 |
| 13 | MP0003436_decreased_susceptibility_to | 2.56203797 |
| 14 | MP0005025_abnormal_response_to | 2.54358079 |
| 15 | MP0000685_abnormal_immune_system | 2.46521747 |
| 16 | MP0001790_abnormal_immune_system | 2.40377460 |
| 17 | MP0005387_immune_system_phenotype | 2.40377460 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.38381034 |
| 19 | MP0006082_CNS_inflammation | 2.35446990 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.28000515 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.23792499 |
| 22 | MP0003866_abnormal_defecation | 2.22622656 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.17732147 |
| 24 | MP0002398_abnormal_bone_marrow | 2.12302387 |
| 25 | MP0000703_abnormal_thymus_morphology | 2.10115354 |
| 26 | MP0002405_respiratory_system_inflammati | 2.08491843 |
| 27 | MP0002419_abnormal_innate_immunity | 2.03481740 |
| 28 | MP0000716_abnormal_immune_system | 2.02511437 |
| 29 | MP0002722_abnormal_immune_system | 1.90519174 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.90173200 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.82738482 |
| 32 | MP0002006_tumorigenesis | 1.78903709 |
| 33 | MP0004381_abnormal_hair_follicle | 1.74496382 |
| 34 | MP0003195_calcinosis | 1.72322287 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.68950539 |
| 36 | MP0001873_stomach_inflammation | 1.65575099 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.61384106 |
| 38 | MP0002429_abnormal_blood_cell | 1.57491787 |
| 39 | MP0004947_skin_inflammation | 1.57221221 |
| 40 | MP0002933_joint_inflammation | 1.55928118 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.53423134 |
| 42 | MP0001661_extended_life_span | 1.52264372 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.36483115 |
| 44 | MP0002009_preneoplasia | 1.36261728 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.34266459 |
| 46 | MP0008469_abnormal_protein_level | 1.29035778 |
| 47 | MP0009764_decreased_sensitivity_to | 1.28387965 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.27959742 |
| 49 | MP0001853_heart_inflammation | 1.22292595 |
| 50 | MP0005310_abnormal_salivary_gland | 1.20009629 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15473360 |
| 52 | MP0003252_abnormal_bile_duct | 1.05504166 |
| 53 | MP0006072_abnormal_retinal_apoptosis | 1.04798965 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.04582317 |
| 55 | MP0001919_abnormal_reproductive_system | 1.02811761 |
| 56 | MP0003786_premature_aging | 0.98875745 |
| 57 | MP0003448_altered_tumor_morphology | 0.96495155 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 0.95905459 |
| 59 | MP0009763_increased_sensitivity_to | 0.93914512 |
| 60 | MP0004043_abnormal_pH_regulation | 0.88227117 |
| 61 | MP0002019_abnormal_tumor_incidence | 0.87698282 |
| 62 | MP0002693_abnormal_pancreas_physiology | 0.86458263 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.84262361 |
| 64 | MP0005360_urolithiasis | 0.83912027 |
| 65 | MP0008872_abnormal_physiological_respon | 0.82464433 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.81755249 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 0.81112835 |
| 68 | MP0003878_abnormal_ear_physiology | 0.81112835 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.81107694 |
| 70 | MP0000604_amyloidosis | 0.80002230 |
| 71 | MP0005451_abnormal_body_composition | 0.77271243 |
| 72 | MP0000372_irregular_coat_pigmentation | 0.75053215 |
| 73 | MP0005389_reproductive_system_phenotype | 0.74672525 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.74549068 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.70371958 |
| 76 | MP0001765_abnormal_ion_homeostasis | 0.70210908 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 0.68541599 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.68235781 |
| 79 | MP0005365_abnormal_bile_salt | 0.67210267 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.66579147 |
| 81 | MP0004147_increased_porphyrin_level | 0.65669292 |
| 82 | MP0003045_fibrosis | 0.62706411 |
| 83 | MP0004130_abnormal_muscle_cell | 0.62256792 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.61881942 |
| 85 | MP0000858_altered_metastatic_potential | 0.60965512 |
| 86 | MP0002102_abnormal_ear_morphology | 0.60938178 |
| 87 | MP0000490_abnormal_crypts_of | 0.60619425 |
| 88 | MP0003646_muscle_fatigue | 0.60413563 |
| 89 | MP0003075_altered_response_to | 0.57819636 |
| 90 | MP0005410_abnormal_fertilization | 0.57483171 |
| 91 | MP0002163_abnormal_gland_morphology | 0.55603335 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.55131666 |
| 93 | MP0004742_abnormal_vestibular_system | 0.54332156 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.54074937 |
| 95 | MP0002254_reproductive_system_inflammat | 0.53548705 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.53444306 |
| 97 | MP0005166_decreased_susceptibility_to | 0.52856790 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.52775982 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.52629692 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.52400157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.66211719 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.02629041 |
| 3 | IgG deficiency (HP:0004315) | 5.82112622 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 4.89221952 |
| 5 | Abnormality of T cells (HP:0002843) | 4.77919980 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31807648 |
| 7 | B lymphocytopenia (HP:0010976) | 4.29176411 |
| 8 | Abnormality of B cell number (HP:0010975) | 4.10875459 |
| 9 | Stomatitis (HP:0010280) | 4.01199677 |
| 10 | Combined immunodeficiency (HP:0005387) | 3.97272866 |
| 11 | Optic neuritis (HP:0100653) | 3.86441848 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.86441848 |
| 13 | Myositis (HP:0100614) | 3.78206402 |
| 14 | Thyroiditis (HP:0100646) | 3.71334750 |
| 15 | Hypoproteinemia (HP:0003075) | 3.48461248 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 3.45826727 |
| 17 | Encephalitis (HP:0002383) | 3.41321835 |
| 18 | Orchitis (HP:0100796) | 3.39626412 |
| 19 | Increased IgM level (HP:0003496) | 3.33403712 |
| 20 | Chronic diarrhea (HP:0002028) | 3.30057562 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.25954020 |
| 22 | Abnormality of eosinophils (HP:0001879) | 3.23332305 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.21315173 |
| 24 | Gangrene (HP:0100758) | 3.17931919 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.09502502 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.09502502 |
| 27 | IgM deficiency (HP:0002850) | 3.04172245 |
| 28 | Lymphopenia (HP:0001888) | 3.02392262 |
| 29 | Recurrent fungal infections (HP:0002841) | 2.98797982 |
| 30 | Keratoconjunctivitis (HP:0001096) | 2.90782308 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90040798 |
| 32 | Joint swelling (HP:0001386) | 2.88416125 |
| 33 | Pustule (HP:0200039) | 2.87883672 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 2.80633881 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.73681671 |
| 36 | Meningitis (HP:0001287) | 2.71793279 |
| 37 | Abnormality of the prostate (HP:0008775) | 2.71146894 |
| 38 | Aplastic anemia (HP:0001915) | 2.69368494 |
| 39 | Leukocytosis (HP:0001974) | 2.62076291 |
| 40 | Congenital stationary night blindness (HP:0007642) | 2.60372347 |
| 41 | Vasculitis (HP:0002633) | 2.59993893 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.56612309 |
| 43 | Renal cortical cysts (HP:0000803) | 2.55826180 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.55672256 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.54932614 |
| 46 | Reduced antithrombin III activity (HP:0001976) | 2.52363970 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.47999696 |
| 48 | Anorexia (HP:0002039) | 2.46476593 |
| 49 | Conical tooth (HP:0000698) | 2.45469580 |
| 50 | Hemoptysis (HP:0002105) | 2.38740236 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.36041813 |
| 52 | Recurrent viral infections (HP:0004429) | 2.35921894 |
| 53 | Parakeratosis (HP:0001036) | 2.35710656 |
| 54 | Recurrent skin infections (HP:0001581) | 2.33287486 |
| 55 | Hypoalbuminemia (HP:0003073) | 2.30500914 |
| 56 | Abnormal albumin level (HP:0012116) | 2.30500914 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.27437965 |
| 58 | Eosinophilia (HP:0001880) | 2.27158389 |
| 59 | Bronchitis (HP:0012387) | 2.25017198 |
| 60 | IgA deficiency (HP:0002720) | 2.21007679 |
| 61 | Abolished electroretinogram (ERG) (HP:0000550) | 2.18315911 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13952620 |
| 63 | Obstructive lung disease (HP:0006536) | 2.13952620 |
| 64 | Lymphoma (HP:0002665) | 2.13275177 |
| 65 | Abnormality of the pons (HP:0007361) | 2.11992264 |
| 66 | Pulmonary embolism (HP:0002204) | 2.10297402 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.09460318 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.08758943 |
| 69 | Abnormal glycosylation (HP:0012345) | 2.08758943 |
| 70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08758943 |
| 71 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08758943 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.08328339 |
| 73 | Acute hepatic failure (HP:0006554) | 2.06911543 |
| 74 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06397125 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.06280385 |
| 76 | Arterial thrombosis (HP:0004420) | 2.03278495 |
| 77 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.02347654 |
| 78 | Acanthocytosis (HP:0001927) | 2.02030126 |
| 79 | Granulocytopenia (HP:0001913) | 1.99782717 |
| 80 | Keratitis (HP:0000491) | 1.98714369 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 1.97816089 |
| 82 | Pancytopenia (HP:0001876) | 1.95559473 |
| 83 | Chest pain (HP:0100749) | 1.92721755 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 1.91405197 |
| 85 | Stomach cancer (HP:0012126) | 1.89828454 |
| 86 | Prostate neoplasm (HP:0100787) | 1.88141284 |
| 87 | Polyneuropathy (HP:0001271) | 1.85462977 |
| 88 | Eczematoid dermatitis (HP:0000976) | 1.84612909 |
| 89 | Long nose (HP:0003189) | 1.82660189 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 1.82542539 |
| 91 | Carpal bone hypoplasia (HP:0001498) | 1.77863664 |
| 92 | Alveolar cell carcinoma (HP:0006519) | 1.73956420 |
| 93 | Pancreatitis (HP:0001733) | 1.73265703 |
| 94 | Hypoplasia of the pons (HP:0012110) | 1.72090003 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71816257 |
| 96 | Erythroderma (HP:0001019) | 1.71749502 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.71730718 |
| 98 | Pancreatic cysts (HP:0001737) | 1.71282968 |
| 99 | Abnormality of the alveolar ridges (HP:0006477) | 1.67904277 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 1.67637672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.11674901 |
| 2 | MAP4K1 | 3.33701218 |
| 3 | GRK6 | 3.17800002 |
| 4 | ITK | 3.16959179 |
| 5 | KDR | 3.15370289 |
| 6 | TAOK3 | 2.95984518 |
| 7 | TEC | 2.74165769 |
| 8 | TESK2 | 2.56765698 |
| 9 | MAP4K2 | 2.56199800 |
| 10 | NME1 | 2.39871798 |
| 11 | ZAK | 2.22683371 |
| 12 | TLK1 | 2.22014925 |
| 13 | BCKDK | 2.18711198 |
| 14 | SYK | 2.08979134 |
| 15 | MAP3K14 | 2.03672950 |
| 16 | IKBKE | 2.01700313 |
| 17 | BTK | 2.01654394 |
| 18 | FES | 1.83826358 |
| 19 | LCK | 1.79875723 |
| 20 | FRK | 1.72904107 |
| 21 | IKBKB | 1.68580792 |
| 22 | ADRBK2 | 1.63179571 |
| 23 | TBK1 | 1.61547954 |
| 24 | ZAP70 | 1.50554353 |
| 25 | CSK | 1.49374511 |
| 26 | NUAK1 | 1.49307772 |
| 27 | INSRR | 1.49136731 |
| 28 | MAP2K2 | 1.49081605 |
| 29 | LYN | 1.41650095 |
| 30 | PRKCQ | 1.38357233 |
| 31 | GRK7 | 1.25558737 |
| 32 | PASK | 1.23554136 |
| 33 | JAK3 | 1.20234395 |
| 34 | IRAK4 | 1.17645294 |
| 35 | TNK2 | 1.12089287 |
| 36 | WNK4 | 1.00472856 |
| 37 | PIM1 | 0.94952073 |
| 38 | HCK | 0.94586285 |
| 39 | JAK1 | 0.90936994 |
| 40 | CSF1R | 0.89854604 |
| 41 | MAP2K6 | 0.87846568 |
| 42 | GRK1 | 0.87631836 |
| 43 | SCYL2 | 0.86786857 |
| 44 | RPS6KA4 | 0.83997617 |
| 45 | RIPK4 | 0.83826239 |
| 46 | PIK3CG | 0.83387322 |
| 47 | TYK2 | 0.82660628 |
| 48 | MST4 | 0.82132380 |
| 49 | CAMKK2 | 0.76187192 |
| 50 | KIT | 0.72636828 |
| 51 | CDK4 | 0.68766270 |
| 52 | MATK | 0.68734390 |
| 53 | NLK | 0.66886303 |
| 54 | LIMK1 | 0.64719315 |
| 55 | ACVR1B | 0.64291386 |
| 56 | IGF1R | 0.61890989 |
| 57 | PINK1 | 0.59131690 |
| 58 | BUB1 | 0.57654362 |
| 59 | BMPR2 | 0.53656435 |
| 60 | BLK | 0.52849257 |
| 61 | VRK1 | 0.51072487 |
| 62 | MAP3K12 | 0.50880114 |
| 63 | PIK3CA | 0.50760298 |
| 64 | FYN | 0.50141346 |
| 65 | ABL1 | 0.47910718 |
| 66 | EIF2AK2 | 0.47737217 |
| 67 | EIF2AK3 | 0.44089640 |
| 68 | EGFR | 0.42083936 |
| 69 | JAK2 | 0.40896143 |
| 70 | CAMKK1 | 0.40032437 |
| 71 | CDK19 | 0.39485389 |
| 72 | CLK1 | 0.38967791 |
| 73 | INSR | 0.38231719 |
| 74 | TESK1 | 0.36562885 |
| 75 | MAPK11 | 0.34674121 |
| 76 | CHUK | 0.34621810 |
| 77 | RPS6KA5 | 0.33168230 |
| 78 | CDK3 | 0.31190742 |
| 79 | MAPK7 | 0.30357323 |
| 80 | FGR | 0.30185649 |
| 81 | PDK1 | 0.28886966 |
| 82 | MARK3 | 0.28817947 |
| 83 | OXSR1 | 0.27012404 |
| 84 | MAP3K13 | 0.26608531 |
| 85 | TGFBR2 | 0.26563302 |
| 86 | WNK1 | 0.26241791 |
| 87 | NEK6 | 0.25831950 |
| 88 | PRKCB | 0.24006122 |
| 89 | TRPM7 | 0.23237893 |
| 90 | MAP3K11 | 0.22958487 |
| 91 | MAPKAPK2 | 0.22392406 |
| 92 | PRKCH | 0.21178920 |
| 93 | MAPK3 | 0.20871866 |
| 94 | BCR | 0.20637495 |
| 95 | BRSK2 | 0.20374884 |
| 96 | PRKCA | 0.19631771 |
| 97 | IRAK1 | 0.19596014 |
| 98 | ATR | 0.18855408 |
| 99 | ERBB3 | 0.18430756 |
| 100 | ADRBK1 | 0.16346260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.90170477 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.47583099 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.22415408 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.16503370 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.09824142 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.02013253 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 3.00522085 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.70438053 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.68148465 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66641020 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.59834505 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.24906769 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21887886 |
| 14 | Measles_Homo sapiens_hsa05162 | 2.05577954 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00343411 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79958075 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58698442 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58398172 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53670311 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41980991 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.39567389 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37878763 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.33351786 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28525752 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19246552 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13604855 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12448673 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12026817 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10112949 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.09038335 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.07294777 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05772486 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05174119 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.04058686 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02311122 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99210903 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98080545 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96485611 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96348391 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94193433 |
| 41 | Protein export_Homo sapiens_hsa03060 | 0.93027447 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91751447 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89544188 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 0.85739779 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83879907 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.81960978 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77173502 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76639665 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76420631 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72377338 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71518036 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70741570 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69997378 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68157700 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.67724583 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65192319 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64531394 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.61982524 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60514215 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55893372 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.53973030 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53764630 |
| 63 | Ribosome_Homo sapiens_hsa03010 | 0.53669108 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.53647642 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53052759 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52965665 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.52912810 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51359782 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50779218 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50696940 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.50561242 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47364135 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47128404 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46837487 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46713531 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46124273 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44948494 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.43884870 |
| 79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43677453 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43479556 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.41691671 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.41043170 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.40060675 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39758228 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39010650 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.33890086 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33324313 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32715498 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30281817 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30007972 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29277803 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29039569 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28268676 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28108480 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27029173 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24705070 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23401375 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22403007 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21398434 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.20766886 |

